title: Preventing mother-to-child transmission of HIV in Western Kenya: operational issues.
abstract: OBJECTIVE
  To improve uptake in a program to prevent mother-to-child HIV transmission and describe lessons relevant for prevention of mother-to-child transmission programs in resource-poor settings.
  
  
  METHODS
  Implementation of a pilot project that evaluates approaches to increase program uptake at health facility level at New Nyanza Provincial General Hospital, a public hospital in western Kenya, an area with high HIV prevalence. Client flow was revised to integrate counseling, HIV testing, and dispensing of single-dose nevirapine into routine antenatal services. The number of facilities providing PMCT services was expanded to increase district-wide coverage. Main outcome measures were uptake of counseling, HIV testing, nevirapine, and estimated program impact.
  
  
  RESULTS
  Uptake of counseling and testing improved from 55 to 68% (P < 0.001), nevirapine uptake from 57% to 70% (P < 0.001), and estimated program impact from 15% to 23% (P = 0.03). Aggregate reports compare well with computer-entered data.
  
  
  CONCLUSIONS
  Addressing institutional factors can improve uptake, but expected program impact remains low for several reasons, including relatively low efficacy of the intervention and missed opportunities in the labor room.
authors.affiliation: Centers for Disease Control and Prevention Kenya, Kisumu, Kenya. avanthoog@kisian.mimcom.net
authors.forename: Anna H
authors.initials: AH
authors.lastname: van't Hoog
authors.forename: Dorothy A
authors.initials: DA
authors.lastname: Mbori-Ngacha
authors.forename: Lawrence H
authors.initials: LH
authors.lastname: Marum
authors.forename: Juliana A
authors.initials: JA
authors.lastname: Otieno
authors.forename: Ambrose O
authors.initials: AO
authors.lastname: Misore
authors.forename: Lucy W
authors.initials: LW
authors.lastname: Nganga
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Decock
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003376:Counseling; D003906:Developing Countries; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission*; D006769:Hospitals, General; D006779:Hospitals, Public; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007630:Kenya; D019829:Nevirapine / Q000627:therapeutic use*; D010865:Pilot Projects; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D015397:Program Evaluation
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine